Rodney James Williams

CIK: 0001722780

Transaction Breakdown

Open Market Buys (P)2 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZOM

Zomedica Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ZOMDF
Zomedica Corp.
Nov 17, 2025
Award(A)
Stock Appreciation Right
Direct
2M shares-
ZOM
Zomedica Corp.
Mar 17, 2025
Purchase(P)
Direct
100K shares at avg. $0.07$7K
ZOM
Zomedica Corp.
Mar 17, 2025
Purchase(P)
Direct
100K shares at avg. $0.07$7K
ZOM
Zomedica Corp.
Nov 10, 2024
Award(A)
Stock Appreciation Rights
Direct
2M shares-

		Type	Shares	Price		Ownership
Nov 17, 2025	ZOMDF Zomedica Corp.	Award(A) Stock Appreciation Right	1,975,033	-	-	Direct
Mar 17, 2025	ZOM Zomedica Corp.	Purchase(P)	100,000	$0.07	$6,900	Direct
Mar 17, 2025	ZOM Zomedica Corp.	Purchase(P)	100,000	$0.07	$6,900	Direct
Nov 10, 2024	ZOM Zomedica Corp.	Award(A) Stock Appreciation Rights	1,975,033	-	-	Direct

1-4 of 4 transactions

About Williams Rodney James

Williams Rodney James (SEC CIK 0001722780) files insider reports with the SEC as Director of Zomedica Corp. (ZOM).

Signal8 holds 4 ownership filings by Williams Rodney James, all Form 4s, filed between Nov 26, 2024 and Nov 18, 2025. Those filings report 4 transactions, from Nov 10, 2024 to Nov 17, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Williams Rodney James's filings is in ANN ARBOR, MI.

Recent filings by Williams Rodney James

Nov 17, 2025: Grant or award of ZOMDF derivative securities (Form 4, code A).
Mar 17, 2025: Open-market purchases of ZOM shares (2 lines, Form 4, code P).
Nov 10, 2024: Grant or award of ZOM derivative securities (Form 4, code A).

Other insiders filing for Zomedica Corp. (ZOM)

How to read Form 4 transaction codes